The quarter cleared a low market bar. Revenue reached $51.4 million versus the published consensus of approximately $49.7 million, while adjusted fully diluted loss was $0.02 per share versus an expected $0.04 loss. That is a real beat, but expectations had already been cut materially ahead of the print.
| Metric | Q2 2026 | Q2 2025 | Market expectation |
|---|---|---|---|
| Revenue | $51.4M (Financial Highlights) | $47.4M (Financial Highlights) | ~$49.7M |
| Adjusted EBITDA | $8.7M (Adjusted EBITDA reconciliation) | $(10.4)M (Adjusted EBITDA reconciliation) | No reliable published consensus found |
| Adjusted fully diluted loss per share | $(0.02) (Adjusted net loss reconciliation) | $(0.08) (Adjusted net loss reconciliation) | $(0.04) |
| GAAP loss per Class A share | $(0.08) (Income Statement) | $(0.27) (Income Statement) | — |
Underlying growth held up better than the headline slowdown suggests. TriLink revenue rose 11.5% year over year to $34.7 million, with Cygnus up 2.8% to $16.8 million; gross profit increased to $20.7 million from $7.8 million as the company’s cost structure improved (Segment results; Income Statement). The quarter also produced positive adjusted EBITDA of $8.7 million, versus a $10.4 million loss a year earlier (Adjusted EBITDA reconciliation).
The sequential picture is less impressive because Q1 was inflated by COVID orders. Revenue fell from $65.8 million in Q1 to $51.4 million in Q2, and adjusted EBITDA declined from $20.3 million to $8.7 million. The filing identifies $14.3 million of high-volume CleanCap orders in Q1 and says those orders are not expected to recur for the rest of 2026 (Business update; Risk factors). That makes the Q2 normalization largely expected rather than a new deterioration, but it limits how much of the reported growth should be treated as durable.
Guidance was not raised, so the beat does not reset the full-year outlook. The filing repeats that 2026 guidance is based on the existing business but does not provide a new numerical range. The prior published outlook was $205 million-$215 million of revenue and $30 million-$32 million of adjusted EBITDA; after six months, Maravai has delivered $117.3 million of revenue and $29.0 million of adjusted EBITDA (Six-month Financial Highlights). The company is therefore running close to its full-year EBITDA target already, but the absence of an updated guide leaves the market without a stronger forward signal.
Net read: modestly better than expected, with quality caveats. The revenue and adjusted-EPS beats matter, and the return to positive operating earnings is substantial year over year. But the comparison is against lowered expectations, the quarter was weaker sequentially after a temporary Q1 CleanCap surge, and management did not raise guidance. That supports a mild positive read rather than a broad re-rating signal.
Read the original 8-K on SEC EDGAR ↗